Nova Leap Health Corp. (NLH.V) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+39.0%

CA$0.67

vs CA$0.48 price

Levered DCF

CA$0.56

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

4.29

Safe zone

Rating

A-

Overall 4 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-92.68×	11.95×	-16.68×	-17.08×	24.11×	29.43×	-18.9×	-11.84×
P/B	0.94×	0.9×	0.96×	0.77×	1.94×	3.89×	2.81×	1.68×
P/S	0.56×	0.64×	0.67×	0.51×	1.69×	2.21×	1.14×	1.1×
EV / EBITDA	9.75×	7.01×	13.42×	40.48×	8.49×	17.6×	47.4×	-51.59×
Gross margin	37.0%	38.4%	37.3%	35.4%	33.9%	33.9%	33.6%	32.0%
Operating margin	3.5%	3.4%	1.8%	-3.9%	18.3%	10.5%	-0.6%	7.4%
Net margin	-0.6%	5.4%	-4.0%	-3.0%	8.3%	7.3%	-6.1%	-9.3%
Current ratio	0.96×	1.06×	1.59×	1×	0.96×	1.04×	0.74×	0.6×
Debt / equity	0.15×	0.14×	0.08×	0.21×	0.34×	0.61×	0.81×	0.68×
Interest coverage	3.16×	8.08×	3.18×	-4.06×	9.71×	4.05×	-0.24×	2.44×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-1.0%	7.6%	-5.8%	-4.5%	9.5%	12.8%	-14.9%	-14.2%
Return on invested capital	5.1%	3.2%	1.8%	-3.4%	11.2%	11.2%	-0.9%	6.2%
Return on assets	-0.8%	6.2%	-5.0%	-3.5%	6.6%	7.2%	-7.5%	-7.7%
Free cash flow yield	7.9%	8.3%	12.1%	6.6%	6.1%	7.8%	3.0%	-13.8%
Earnings yield	-1.1%	8.4%	-6.0%	-5.8%	4.9%	3.3%	-5.3%	-8.5%
Enterprise value	CA$19.2M	CA$17.5M	CA$18.1M	CA$17M	CA$40.3M	CA$41.5M	CA$24M	CA$14.7M
Net debt / EBITDA	0.73×	0.45×	0.37×	6.41×	0.94×	1.35×	8.06×	-11.72×
Cash conversion cycle (days)	-4	-12	-3	-1	11	-1	12	45